Literature DB >> 7986583

HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells.

J Rautonen1, N Rautonen, N L Martin, D W Wara.   

Abstract

Tat is a potent trans-activating protein encoded by the HIV genome. It is essential for viral replication, but has pleiotropic effects on host cells as well. We demonstrated that exogenous recombinant Tat increases immunoglobulin (Ig) and interleukin 6 (IL-6) production in vitro by normal uninfected peripheral blood mononuclear cells by 100-500%. The optimal Tat concentration was 100 ng/ml, but even a low concentration of 1 ng/ml induced a response in most subjects. The observed induction was inhibited by monoclonal anti-Tat antibodies and 2,3-dimercapto-1-propanol. Both anti-IL-6 antibodies and IL-6 antisense oligonucleotides inhibited Tat-induced IgG and IgA synthesis to some degree, whereas induction of IgM appeared to be independent of IL-6. We conclude that Tat can function in vitro in the absence of any other viral structures and induce Ig and IL-6 production; the clinical significance of these findings remains as yet undetermined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986583     DOI: 10.1089/aid.1994.10.781

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.

Authors:  F Lechner; J Machado; G Bertoni; H F Seow; D A Dobbelaere; E Peterhans
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

Authors:  F Kashanchi; E T Agbottah; C A Pise-Masison; R Mahieux; J Duvall; A Kumar; J N Brady
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.

Authors:  K Conant; M Ma; A Nath; E O Major
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.

Authors:  Justine K Wong; Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

6.  Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice.

Authors:  G Altavilla; C Trabanelli; M Merlin; A Caputo; M Lanfredi; G Barbanti-Brodano; A Corallini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 7.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 disease.

Authors:  Carey L Shive; Angélique Biancotto; Nicholas T Funderburg; Heather A Pilch-Cooper; Hernan Valdez; Leonid Margolis; Scott F Sieg; Grace A McComsey; Benigno Rodriguez; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

Review 9.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

10.  The expression of HIV-1 tat and nef genes induces cell-specific changes in growth properties and morphology of different types of rat cells.

Authors:  Irina Shugurova; Irina Bobrisheva; Irina Surkova; Igor Grivennikov; Vyacheslav Tarantul
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.